A Unites States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 5, 1997, Pages 913-917

  Laine, L ^a   Frantz, J E ^b   Baker, A ^b   Neil, G A ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Astra Merck   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; HELICOBACTER INFECTION; MIDDLE AGED; UNITED STATES;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; UNITED STATES;

EID: 0030611919     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00230.x     Document Type: Article

References (12)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Bazzoli F, Zagari RM, Fossi S. et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
3. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 Study. Helicobacter 1996; 1: 138-44.
4. Breuer T, Sudhop T, Malaty HM, Goodman K, Graham DY, Balfertheiner P. Do physicians from different countries treat H. pylori positive ulcer disease differently; a comparison between America and Germany. Gut 1996; 39(Suppl. 3): 189 (Abstract).
5. Laine L, Stein C, Neil G. Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing 'optimal' dosing. Am J Gastroenterol 1995; 90: 1407-10.
6. Graham KS, Malaty H, el-Zimaity HM, et al. Variability with omeprazole-amoxicillin combination for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 1415-8.
7. Labenz J, Ruhl GH, Bertrams J, Borsch G, Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci 1994; 39: 1483-7.
8. Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.
9. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of differing periods of twice-a-day therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10: 1029-33.
10. Yousfi MM, El-Zimaity Cole RA, Genta RM, Graham DY. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 617.
11. Schwartz H, Krause R, Siepman N, et al. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. Helicobacter 1996; 1: 251-5.
12. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multicentre, randomised trial. Gastroenterology 1996; 110: 198(Abstract).